Multidisciplinary: pharmacogenomics

The European Medicines Agency's scientific guidelines on pharmacogenomics (PG) help medicine developers prepare marketing authorisation applications for human medicines.

If you have comments on a document which is open for consultation, use the Microsoft Office document iconform for submission of comments on scientific guidelines .

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

PG considerations during drug life cycle

Guidance on technical PG aspects

Therapeutic-specific PG guidance

Procedural guidance

How useful was this page?

Add your rating